|
Année 2009 |
|
|
Changing the teaching of neurosurgery with information technology
Moreau JJ, Caire F, Kalamarides M, Mireau E, Dauger F, Coignac MJ, Charlin B.
Presse Med. 2009 Oct;38(10):1425-33. Epub 2009 Sep 18. French.
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2.
Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, Korf B, Kurzrock R, Law M, McClatchey A, Packer R, Roehm P, Rubenstein A, Slattery W 3rd, Tonsgard JH, Welling DB, Widemann B, Yohay K, Giovannini M.
Clin Cancer Res. 2009 Aug 15;15(16):5032-9. Epub 2009 Aug 11.
WHO grade II and III meningiomas: a study of prognostic factors.
Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamaridès M, Menei P, Deruty R, Moreau JJ, Fèvre-Montange M, Guyotat J.
J Neurooncol. 2009 Dec;95(3):367-75. Epub 2009 Jun 27.
Processing of voices in deafness rehabilitation by auditory brainstem implant.
Coez A, Zilbovicius M, Ferrary E, Bouccara D, Mosnier I, Ambert-Dahan E, Kalamarides M, Bizaguet E, Syrota A, Samson Y, Sterkers O.
Neuroimage. 2009 Oct 1;47(4):1792-6. Epub 2009 May 27.
Do facial nerve displacement pattern and tumor adhesion influence the facial nerve outcome in vestibular schwannoma surgery ?
Esquia-Medina GN, Grayeli AB, Ferrary E, Tubach F, Bernat I, Zhang Z, Bianchi C, Kalamarides M, Sterkers O.
Otol Neurotol. 2009 Apr;30(3):392-7.
Use of anatomic or invasive markers in association with skin surface registration in image-guided surgery of the temporal bone.
Grayeli AB, Esquia-Medina G, Nguyen Y, Mazalaigue S, Vellin JF, Lombard B, Kalamarides M, Ferrary E, Sterkers O.
Acta Otolaryngol. 2009 Apr;129(4):405-10.
|
|
|
|
Année 2005 |
|
|
Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin.
Magalhaes JG, Philpott DJ, Nahori MA, Jehanno M, Fritz J, Bourhis LL, Viala J, Hugot JP, Giovannini M, Bertin J, Lepoivre M, Mengin-Lecreulx D, Sansonetti PJ, Girardin SE.
EMBO Rep. 2005 Dec;6(12):1201-7.
Similar Tumor Suppressor Gene Alteration Profiles in Asbestos-Induced Murine and Human Mesothelioma.
Lecomte C, Andujar P, Renier A, Kheuang L, Abramowski V, Mellottee L, Fleury-Feith J, Zucman-Rossi J, Giovannini M, Jaurand MC.
Cell Cycle. 2005 4(12):1862-9.
Bioluminescence imaging of live infected salmonids reveals that the fin bases are the major portal of entry for Novirhabdovirus.
Harmache A, LeBerre M, Droineau S, Giovannini M, Bremont M.
J Virol. 2006 Apr;80(7):3655-9.
Merlin/NF2 suppresses growth by inhibiting the activation of Ras and Rac
Morrison H., Sperka T., Manent J., Giovannini M., Ponta H. Herrlich P.
EMBO J. 2006 in press
Membrane organization and tumorigenesis - the NF2 tumor suppressor, merlin
McClatchey A. and M. Giovannini.
Genes & Development, 19:2265-2277 (2005)
|
|
|
|
Année 2004 |
|
|
Comparative Pathology of Nerve Sheath Tumors in mouse models and humans
Anat O. Stemmer-Rachamimov, D. N. Louis, P. G. Nielsen, C. R. Antonescu, A. D. Borowsky, R. T. Bronson, D. K. Burns, P. Cervera, M. E. McLaughlin, G. Reifenberger, M. C. Schmale, M. MacCollin, R. C. Chao, K. Cichowski, M. Kalamarides, S. M. Messerli, A. I. McClatchey, M. Niwa-Kawakita, N. Ratner, K.M. Reilly, Y. Zhu, and M. Giovannini.
Cancer Research, 2004, 64 :3718-3724
Early Nf2 inactivation in neural crest-derived cells hemizygous
for p53 converts the tumor spectrum from osteogenic to peripheral nerve
sheath tumors
Robanus-Maandag E.*, Giovannini M.*, van der Valk M., Niwa-Kawakita M., Abramowski V., Woodruff J.M., Thomas G., Berns A.
Oncogene, 2004, 23 :6541-6547
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C.
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17216-21. Epub 2004 Nov 24
|
|
|
|
Année 2003 |
|
|
Hemizygosity of Nf2 is associated with increased susceptibility ot asbestos-induced peritoneal tumours.
Fleury-Feith J., Lecomte C., Renier A., Matrat M., Kheuang L., Abramowski A., Levy F., Janin A., Giovannini M., and Jaurand M-C.
Oncogene, 2003, 22:3799-3805
Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves
Manent J., Oguievetskaia X., Bayer J., Ratner N., and Giovannini M.
J. Neuroscience Meth., 2003, 123 : 167-173.
Nf2 deficiency promotes tumorigenesis and metastasis destabilizing adherens junctions.
Lallemand D., Curto M., Saotome I., Giovannini M., McClatchey A
Genes & Development, 2003, 17 (9) 1090-1100
|
|
|
|
Années 2002 et antérieures |
|
|
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, Thomas G, Gutmann D, and Giovannini M.
Genes & Development, 16:1060-1065 (2002)
Targeted expression of Cre recombinase to myelinating cells of the central nervous system in transgenic mice.
Niwa-Kawakita M, Abramowski V, Kalamarides M, Thomas G, and Giovannini M.
Genesis, 2000, 26: 127-129.
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2..
Giovannini M, Robanus-Maandag E, van der Valk M, Niwa-Kawakita M,
Abramowski V, Goutebroze L, Woodruff JM, Berns A, and Thomas G.
Genes & Development, 2000, 14: 1617-1630.
Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occuring mutant NF2 protein.
Giovannini M, Robanus-Maandag E, Kawakita M, van der Valk M,Woodruff J, Goutebroze L, Mérel P, Berns A, Thomas G.
Genes & Development, 1999, 13: 978-986.
|
|
|
|
Les publications récentes 
